
Targacept and Catalyst Biosciences have signed a merger agreement which will see them develop new treatment options for patients with …
The fall-out from pipeline difficulties has led US biopharma company Targacept to make almost half its workforce redundant. In March …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

